EPITOPE MAPPING OF THE ANTI-HUMAN PROGESTERONE-RECEPTOR MONOCLONAL-ANTIBODY, AB-52

被引:10
作者
TAKIMOTO, GS
TASSET, DM
MILLER, LA
HORWITZ, KB
机构
[1] UNIV COLORADO,HLTH SCI CTR,DEPT MED,4200 E 9TH AVE,B151,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT PATHOL,DENVER,CO 80262
关键词
D O I
10.1016/0960-0760(91)90368-F
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The monoclonal antibody AB-52 has high affinity and specificity for the two natural human progesterone receptor forms, receptor A (hPR(A)) and receptor B (hPR(B)), but it does not bind the PR of chick, mice, rats or rabbits. We have used a novel method to map its epitope. Based on a series of site-directed mutants of hPR(A), together with immunoblotting, DNA gel mobility shift and antibody super shift assays, we have mapped the epitope of AB-52 to a 17 amino acid sequence lying between Val221 and Leu237 of the 933 amino acid hPR(B) protein. This N-terminal sequence is common to both hPR(B) and hPR(A) but is missing in chick PR and differs extensively from mouse PR. No anti-rabbit PR antibodies map to the homologous rabbit PR sequence which differs from hPR by four amino acids, suggesting that one or more of these four amino acids form a critical subset of residues in hPR that define the human specificity of AB-52. Knowledge of the AB-52 epitope is useful in structural analyses of PR, and in competition studies. Additionally, this 17 amino acid peptide whose antigenicity would not be predicted from computer analysis, should be useful for generating additional hPR specific antibodies.
引用
收藏
页码:687 / 692
页数:6
相关论文
共 24 条
[1]  
ATASSI MZ, 1986, METHOD ENZYMOL, V121, P69
[2]   STEROID HORMONE-DEPENDENT INTERACTION OF HUMAN PROGESTERONE-RECEPTOR WITH ITS TARGET ENHANCER ELEMENT [J].
BAGCHI, MK ;
ELLISTON, JF ;
TSAI, SY ;
EDWARDS, DP ;
TSAI, MJ ;
OMALLEY, BW .
MOLECULAR ENDOCRINOLOGY, 1988, 2 (12) :1221-1229
[3]   EXPRESSION OF A BETA-GLOBIN GENE IS ENHANCED BY REMOTE SV40 DNA-SEQUENCES [J].
BANERJI, J ;
RUSCONI, S ;
SCHAFFNER, W .
CELL, 1981, 27 (02) :299-308
[4]   PROGESTERONE-RECEPTOR DETERMINATION IN HUMAN-BREAST TUMORS BY IMMUNOCYTOCHEMICAL AND BIOCHEMICAL TECHNIQUES [J].
CAPPELLETTI, V ;
PATRIARCA, C ;
GRANATA, G ;
CATTORETTI, G ;
CORADINI, D ;
DIFRONZO, G ;
HORWITZ, K .
BREAST CANCER RESEARCH AND TREATMENT, 1989, 14 (02) :217-225
[5]   EMPIRICAL PREDICTIONS OF PROTEIN CONFORMATION [J].
CHOU, PY ;
FASMAN, GD .
ANNUAL REVIEW OF BIOCHEMISTRY, 1978, 47 :251-276
[6]  
CONNEELY OM, 1989, J BIOL CHEM, V264, P14062
[7]   HUMAN PROGESTERONE-RECEPTOR COMPLEXED WITH THE ANTAGONIST RU-486 BINDS TO HORMONE RESPONSE ELEMENTS IN A STRUCTURALLY ALTERED FORM [J].
ELASHRY, D ;
ONATE, SA ;
NORDEEN, SK ;
EDWARDS, DP .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (10) :1545-1558
[8]  
ELASHRY D, 1989, THESIS U COLORADO HL
[9]   IMMUNOLOGICAL ANALYSIS OF HUMAN-BREAST CANCER PROGESTERONE RECEPTORS .1. IMMUNOAFFINITY PURIFICATION OF TRANSFORMED RECEPTORS AND PRODUCTION OF MONOCLONAL-ANTIBODIES [J].
ESTES, PA ;
SUBA, EJ ;
LAWLERHEAVNER, J ;
ELASHRYSTOWERS, D ;
WEI, LL ;
TOFT, DO ;
SULLIVAN, WP ;
HORWITZ, KB ;
EDWARDS, DP .
BIOCHEMISTRY, 1987, 26 (19) :6250-6262
[10]   EQUILIBRIA AND KINETICS OF LAC REPRESSOR-OPERATOR INTERACTIONS BY POLYACRYLAMIDE-GEL ELECTROPHORESIS [J].
FRIED, M ;
CROTHERS, DM .
NUCLEIC ACIDS RESEARCH, 1981, 9 (23) :6505-6525